HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction.

AbstractOBJECTIVES:
The objective of this study is to assess trends in evidence-based therapy use and short- and long-term mortality over time among older patients with non-ST-segment elevation myocardial infarction (NSTEMI).
BACKGROUND:
With the prevalence of national quality improvement efforts, the use of evidence-based therapies has improved over time among patients with NSTEMI, yet it is unclear whether these improvements have been associated with significant change in short- and long-term mortality for older patients.
METHODS:
We linked detailed clinical data for 28,603 NSTEMI patients aged ≥65 years at 171 hospitals in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry with longitudinal Centers for Medicare & Medicaid claims data and compared trends in annual unadjusted and risk-adjusted inhospital and long-term mortality from 2003 to 2006.
RESULTS:
The median age of our NSTEMI study population was 77 years, 48% were female, and 87% were white. Overall, inhospital and 1-year mortality rates were 6.0% and 24.5%, respectively. When compared with patients treated in 2003, NSTEMI patients treated in 2006 were more likely to receive guideline-recommended inhospital medications and early invasive treatment. Inhospital mortality decreased significantly over the study period (5.5% vs 7.2% [adjusted odds ratio 0.82, 95% CI 0.67-1.00, P = .045] for 2006 vs 2003), but there was no significant change in 1-year mortality from the index admission (24.0% vs 26.0% [adjusted hazard ratio 0.99, 95% CI 0.90-1.08] for 2006 vs 2003).
CONCLUSIONS:
Between 2003 and 2006, there was a significant reduction in inhospital mortality that corresponded to an increase in the use of evidence-based NSTEMI care. Nevertheless, long-term outcomes have not changed over time, suggesting a need for improved care transition and longitudinal secondary prevention.
AuthorsChee Tang Chin, Tracy Y Wang, Anita Y Chen, Robin Mathews, Karen P Alexander, Matthew T Roe, Eric D Peterson
JournalAmerican heart journal (Am Heart J) Vol. 167 Issue 1 Pg. 36-42.e1 (Jan 2014) ISSN: 1097-6744 [Electronic] United States
PMID24332140 (Publication Type: Journal Article, Observational Study)
Copyright© 2014 Mosby, Inc. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Cardiology (standards)
  • Evidence-Based Medicine
  • Female
  • Guideline Adherence
  • Hospital Mortality
  • Humans
  • Male
  • Myocardial Infarction (drug therapy, mortality, prevention & control, therapy)
  • Prognosis
  • Quality Improvement
  • Registries
  • Secondary Prevention
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: